{
  "query": "INSERT INTO blogPosts (title, slug, excerpt, content, category, tags, authorId, authorName, authorCredentials, readTime, viewCount, isPublished, publishedAt, createdAt, updatedAt) VALUES ('Optimizing SBRT Treatment Planning for Lung Cancer: A Practical Guide', 'optimizing-sbrt-lung-cancer-treatment-planning', 'Comprehensive strategies for achieving optimal dose distribution and minimizing toxicity in stereotactic body radiation therapy for lung cancer patients.', '# Optimizing SBRT Treatment Planning for Lung Cancer\\n\\nSBRT has revolutionized early-stage NSCLC treatment. This guide explores evidence-based strategies for optimizing treatment planning.\\n\\n## Key Planning Objectives\\n\\n- Tumor Coverage: 95-99% PTV coverage\\n- Dose Conformity: CI of 1.0-1.2\\n- Gradient Index: GI < 5.0\\n- OAR Sparing: Strict dose constraints\\n\\n## Conclusion\\n\\nOptimizing SBRT requires meticulous attention to target delineation, dose prescription, and quality assurance.', 'clinical-practice', 'SBRT, lung cancer, treatment planning', 1, 'Dr. Sarah Chen', 'MD, DABR', 8, 0, 1, '2025-01-15', NOW(), NOW())",
  "command": "mysql --batch --raw --column-names --default-character-set=utf8mb4 --host gateway02.us-east-1.prod.aws.tidbcloud.com --port 4000 --user 345pWMaQPV1VyKp.5c2d3a564afb --database H7NKxTnRHVSBYRhL64LnAp --execute INSERT INTO blogPosts (title, slug, excerpt, content, category, tags, authorId, authorName, authorCredentials, readTime, viewCount, isPublished, publishedAt, createdAt, updatedAt) VALUES ('Optimizing SBRT Treatment Planning for Lung Cancer: A Practical Guide', 'optimizing-sbrt-lung-cancer-treatment-planning', 'Comprehensive strategies for achieving optimal dose distribution and minimizing toxicity in stereotactic body radiation therapy for lung cancer patients.', '# Optimizing SBRT Treatment Planning for Lung Cancer\\n\\nSBRT has revolutionized early-stage NSCLC treatment. This guide explores evidence-based strategies for optimizing treatment planning.\\n\\n## Key Planning Objectives\\n\\n- Tumor Coverage: 95-99% PTV coverage\\n- Dose Conformity: CI of 1.0-1.2\\n- Gradient Index: GI < 5.0\\n- OAR Sparing: Strict dose constraints\\n\\n## Conclusion\\n\\nOptimizing SBRT requires meticulous attention to target delineation, dose prescription, and quality assurance.', 'clinical-practice', 'SBRT, lung cancer, treatment planning', 1, 'Dr. Sarah Chen', 'MD, DABR', 8, 0, 1, '2025-01-15', NOW(), NOW())",
  "rows": [],
  "messages": [],
  "stdout": "",
  "stderr": "",
  "execution_time_ms": 70
}